Close Menu

NEW YORK (360Dx) – RenalytixAI announced today that it has signed an agreement with Akesogen for a partnership that aims to increase testing capacity and support pharmaceutical services.

Through the joint venture, called Renx AI Labs, the partnership will provide services directly to health systems and pharmaceutical companies located in the US. The venture will allow RenalytixAI to operate outside of its New York City-based clinical lab at JLABS, a Johnson & Johnson Innovation center.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.